- Filed
- Nov 13, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 11, 2024 | 22.22M sh |
| Stock Issued | Q3 2024 · Sep 30, 2024 | 984.33K sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $551.48K |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $872.34K |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $9.18M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $3.62M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $14.48M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $16.29M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $2.97M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $3.83M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $16.85M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $18.48M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 23.58M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 23.58M sh |
| Capex | Q3 2024 · Sep 30, 2023 | $29.78K |
| Operating Cash Flow restated | Q3 2024 · Sep 30, 2023 | $1.06M |
| Stockholders Equity restated | Q3 2024 · Sep 30, 2023 | $2.08M |
| Stockholders Equity restated | Q3 2024 · Jun 30, 2023 | $1.92M |
| Stockholders Equity restated | Q3 2024 · Dec 31, 2022 | $710.21K |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.01 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | $0.06 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.01 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | $0.06 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $519.29K |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $1.56M |
| Net Income restated | Q3 2024 · Sep 30, 2023 | $154.51K |
| Net Income | Q3 2024 · Sep 30, 2023 | $1.35M |
| Operating Income | Q3 2024 · Sep 30, 2023 | $513.95K |
| Operating Income | Q3 2024 · Sep 30, 2023 | $2.74M |
| Revenue | Q3 2024 · Sep 30, 2023 | $3.74M |
| Revenue | Q3 2024 · Sep 30, 2023 | $11.04M |